AbbVie

OverviewSuggest Edit

AbbVie is a pharmaceutical company that discovers, develops, and markets oncology, virology, metabolics and hormones, endocrinology, and other products. Its products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. The company sells its products directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers.

TypePublic
Founded2013
HQLake Bluff, IL, USMap
Websiteabbvie.com
Employee Ratings4More
Overall CultureA+More
View Jobs (1,494)

Recent NewsAll News

Latest Updates

Employees (est.) (Jan 2020)29,160(-1%)
Job Openings1,494
Revenue (FY, 2020)$45.8 B(+38%)
Share Price (Apr 2021)$105.2
Cybersecurity ratingCMore

Key People/Management at AbbVie

Richard A. Gonzalez

Richard A. Gonzalez

Chairman of the Board and Chief Executive Officer
Michael E. Severino

Michael E. Severino

Vice Chairman and President
Laura J. Schumacher

Laura J. Schumacher

Vice Chairman, External Affairs and Chief Legal Officer
Carlos Alban

Carlos Alban

Vice Chairman, Chief Commercial Officer
Rae L. Livingston

Rae L. Livingston

Chief Equality Officer
Henry O. Gosebruch

Henry O. Gosebruch

Executive Vice President, Chief Strategy Officer
Show more

AbbVie Office Locations

AbbVie has offices in Lake Bluff, Cambridge, Mettawa, North Chicago and in 59 other locations
Lake Bluff, IL, US (HQ)
1 Waukegan Rd
Cambridge, MA, US
200 Sidney St
Mettawa, IL, US
26525 Riverwoods Blvd
North Chicago, IL, US
1401 Sheridan Rd
Redwood City, CA, US
1500 Seaport Blvd
South San Francisco, CA, US
450 E Jamie Ct
Show all (67)

AbbVie Financials and Metrics

AbbVie Revenue

Embed Graph
View revenue for all periods
AbbVie's revenue was reported to be $45.8 b in FY, 2020
USD

Revenue (FY, 2020)

45.8b

Gross profit (FY, 2020)

30.4b

Gross profit margin (FY, 2020), %

66.4%

Net income (FY, 2020)

4.6b

EBIT (FY, 2020)

11.4b

Market capitalization (7-Apr-2021)

186.0b

Closing stock price (7-Apr-2021)

105.2

Cash (30-Sept-2020)

7.9b

EV

265.1b
AbbVie's current market capitalization is $186 b.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

25.6b28.2b32.8b33.3b45.8b

Revenue growth, %

12%10%16%2%

Cost of goods sold

5.8b7.0b7.7b7.4b15.4b

Gross profit

19.8b21.2b25.0b25.8b30.4b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

6.5b6.9b7.0b7.9b8.3b8.2b7.8b8.3b8.5b8.6b10.4b12.9b

Cost of goods sold

1.6b1.5b1.6b1.9b1.9b1.8b1.7b1.8b1.9b1.9b3.7b5.1b

Gross profit

4.9b5.4b5.4b6.0b6.3b6.4b6.1b6.4b6.6b6.7b6.7b7.9b

Gross profit Margin, %

75%78%77%76%77%78%78%78%77%77%64%61%
show all
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

5.1b9.3b7.3b39.9b

Accounts Receivable

4.8b5.1b5.4b5.4b

Prepaid Expenses

3.6b4.7b1.9b2.4b

Inventories

1.4b1.6b1.6b1.8b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

4.7b6.1b8.4b9.0b3.5b8.0b4.9b5.2b10.6b41.1b6.0b7.9b

Accounts Receivable

4.7b4.9b4.9b5.8b5.8b5.8b5.7b5.5b5.5b6.4b8.4b8.4b

Prepaid Expenses

3.2b3.3b2.7b3.4b2.7b2.1b1.8b2.3b2.1b2.4b2.8b3.2b

Inventories

1.4b1.6b1.8b1.7b1.6b1.8b1.7b1.9b1.9b1.8b4.1b3.5b
show all
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

6.0b5.3b5.7b7.9b4.6b

Depreciation and Amortization

1.2b1.5b1.8b2.0b6.5b

Inventories

(38.0m)93.0m(226.0m)(231.0m)(40.0m)

Accounts Payable

(1.2b)425.0m190.0m(1.1b)1.5b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

1.7b3.6b5.3b2.8b4.8b7.5b2.5b3.2b5.1b3.0b2.3b4.6b

Depreciation and Amortization

374.0m753.0m1.1b445.0m888.0m1.3b503.0m1.0b1.5b559.0m264.0m4.4b

Inventories

71.0m1.0m(119.0m)(71.0m)(191.0m)(367.0m)(128.0m)(288.0m)(401.0m)(107.0m)(304.0m)(193.0m)

Accounts Payable

(266.0m)(530.0m)444.0m191.0m12.0m881.0m94.0m(1.3b)(582.0m)1.1b466.0m1.9b
show all
USDFY, 2016

Revenue/Employee

915.6k

Debt/Equity

7.9 x

Debt/Assets

0.6 x

Financial Leverage

14.3 x
Show all financial metrics

AbbVie Operating Metrics

AbbVie's Patients was reported to be 52 m in FY, 2019.
FY, 2018FY, 2019

Countries

175175

Partners

220

Patients

30 m52 m

Programs

292
Show all operating metrics

AbbVie Acquisitions / Subsidiaries

Company NameDateDeal Size
MavupharmaJuly 15, 2019
AllerganJune 25, 2019$80 b
Stem CentRxApril 28, 2016$5.8 b
Pharmacyclics IncMarch 04, 2015
ImmuVenJanuary 01, 2014
AbbVie AB
AbbVie AG
AbbVie AS
AbbVie A/S
AbbVie Australasia Holdings Limited
Show more

AbbVie Revenue Breakdown

Embed Graph

AbbVie revenue breakdown by geographic segment: 28.1% from International and 71.9% from United States

Human Capital Metrics

Source: www.abbvie.com
Embed Graph
Show all human capital metrics

AbbVie Cybersecurity Score

Cybersecurity ratingPremium dataset

C

76/100

Learn more about our premium products
SecurityScorecard logo

AbbVie Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

Learn more about our premium products
CSRHub logo

AbbVie Online and Social Media Presence

AbbVie's Trends

Embed Graph

AbbVie Company Culture

  • Overall Culture

    A+

    80/100

  • CEO Rating

    A+

    81/100

  • Compensation

    A

    79/100

  • Diversity

    A+

    81/100

Learn more on Comparably

AbbVie News and Updates

March 30, 2021

Outlook on the Acne Treatment Global Market to 2025 - Players Include Vyne Therapeutics, Bausch Health Companies and Abbvie

Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Global Acne Treatment Market: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com's offering.
March 17, 2021

AbbVie Shares Cross 5% Yield Mark

In trading on Wednesday, shares of AbbVie were yielding above the 5% mark based on its quarterly dividend (annualized to $5.2), with the stock changing hands as low as $102.80 on the day.
March 17, 2021

AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Adults with Active Psoriatic Arthritis

NORTH CHICAGO, Ill., March 17, 2021 /PRNewswire/ -- AbbVie (NYSE:ABBV), a global research and development-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for...
March 11, 2021

Global Parkinson's Disease Drugs Outlook to 2027, Featuring AbbVie Inc., Impax Laboratories Inc., Mylan NV, Orion Pharma and Pfizer Inc.

Dublin, March 11, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Parkinson's Disease Drugs estimated at US$ 5.1 Billion in the year 2020,…
February 25, 2021

Insights on the BCL-2 (B Cell Lymphoma 2) Inhibitors Global Market to 2025 - Players Include Abbvie, Amgen and Novartis Among Others

Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Global BCL-2 (B Cell Lymphoma 2) Inhibitors Market & Clinical Trials Insight 2025" report has been added to ResearchAndMarkets.com's offering.
February 05, 2021

Global Anti-Parkinson Drugs Market Report 2020-2030: Major Players are GlaxoSmithKline plc, Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie Inc. and Mylan

DUBLIN, Feb. 5, 2021 /PRNewswire/ -- The "Anti-Parkinson Drugs Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Anti-Parkinson Drugs Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists,...
Show more

 AbbVie Frequently Asked Questions

  • When was AbbVie founded?

    AbbVie was founded in 2013.

  • Who are AbbVie key executives?

    AbbVie's key executives are Richard A. Gonzalez, Michael E. Severino and Laura J. Schumacher.

  • How many employees does AbbVie have?

    AbbVie has 29,160 employees.

  • What is AbbVie revenue?

    Latest AbbVie annual revenue is $45.8 b.

  • What is AbbVie revenue per employee?

    Latest AbbVie revenue per employee is $1.6 m.

  • Who are AbbVie competitors?

    Competitors of AbbVie include Astellas Pharma, Gilead Sciences and Immunomedics.

  • Where is AbbVie headquarters?

    AbbVie headquarters is located at 1 Waukegan Rd, Lake Bluff.

  • Where are AbbVie offices?

    AbbVie has offices in Lake Bluff, Cambridge, Mettawa, North Chicago and in 59 other locations.

  • How many offices does AbbVie have?

    AbbVie has 67 offices.